Similar articles

• [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].

  Kharchenko VI, Savenkov PM, Romanova LV, Arkhipov SN, Borisova GG. Kharchenko VI, et al. Sov Med. 1983;(9):84-8. Sov Med. 1983. PMID: 6648691 Russian. No abstract available.
• [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].

  Rossano P, Saffiotti O, Mayer MC, Blasich M, Rossano G, Bellotti P. Rossano P, et al. Minerva Cardioangiol. 1980 May;28(5):309-14. Minerva Cardioangiol. 1980. PMID: 6111048 Italian. No abstract available.
• [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].

  Holzer H, Pogglitsch H, Katschnig H, Korthals C. Holzer H, et al. Wien Med Wochenschr Suppl. 1981;69:10-3. Wien Med Wochenschr Suppl. 1981. PMID: 6952657 German.
• Labetalol and the management of hypertension.

  Reid JL, Meredith PA, Elliott HL. Reid JL, et al. J Cardiovasc Pharmacol. 1981;3 Suppl 1:S60-8. doi: 10.1097/00005344-198100031-00007. J Cardiovasc Pharmacol. 1981. PMID: 6169961 Review. No abstract available.
• [Hypertensive emergency].

  Seki A. Seki A. Nihon Rinsho. 2000 Feb;58 Suppl 2:392-6. Nihon Rinsho. 2000. PMID: 11028364 Review. Japanese. No abstract available.